SEC Filing Summary: ADVENTRX Pharmaceuticals, Inc.
Business Context and Reporting Period
This Form 8-K was filed by ADVENTRX Pharmaceuticals, Inc. on May 12, 2009. The filing serves to disseminate a press release regarding the company's financial results for the three-month period ended March 31, 2008. The registrant is incorporated in Delaware and maintains its principal executive offices in San Diego, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts solely as a conduit to a press release (Exhibit 99.1) which contains the actual financial data. Consequently, no quantitative financial metrics can be extracted from this specific text.
Material Changes
The filing references the announcement of results for the quarter ended March 31, 2008. However, the text does not detail specific material changes, year-over-year comparisons, or variances against prior periods. The filing explicitly states that the information is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into other filings.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or discussion of unusual items. The content is limited to the administrative disclosure of the press release issuance.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing Exhibit 99.1 (Press Release dated May 12, 2009), as they are not included in the 8-K text.
- Confirm the discrepancy between the filing date (May 12, 2009) and the reporting period referenced in the text (March 31, 2008) to ensure the correct historical data is being analyzed.
- Note that the registrant name in the metadata request ("Savara Inc") differs from the registrant name in the filing ("ADVENTRX Pharmaceuticals, Inc."); verify if a name change or corporate restructuring occurred.